AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30903962 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 60
Study 28810355 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-affective preparation session
Number of subjects: 128
Study 28810355 — intervention group
Group type: COMPARATOR
Intervention: General health education session
Number of subjects: 128
Study 27505305 — intervention group
Group type: EXPERIMENTAL
Intervention: SAPT with PLGM (predictive algorithm)
Number of subjects: 25
Study 27505305 — intervention group
Group type: COMPARATOR
Intervention: SAPT alone (control)
Number of subjects: 25
Study 25270545 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-volume implant in 1 breast and an adjustable-volume implant in the other
Number of subjects: 60
Study 25270545 — intervention group
Group type: COMPARATOR
Intervention: Two fixed-volume implants of different sizes
Number of subjects: 60
Study 22920839 — intervention group
Group type: EXPERIMENTAL
Intervention: Sling exercise therapy (ST)
Number of subjects: 50
Study 22920839 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapy (PT)
Number of subjects: 50
Study 20703977 — intervention group
Group type: EXPERIMENTAL
Intervention: Thera‐Band (®) Exercise Station Group (TBG)
Number of subjects: 42
Study 20703977 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight machines/free weights group (MFWG)
Number of subjects: 42
Study 20703977 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 42
Study 16973668 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic 0.18% sodium hyaluronate
Number of subjects: 10
Study 16973668 — intervention group
Group type: COMPARATOR
Intervention: Isotonic 0.3% hydroxypropyl‐methylcellulose (HPMC)/0.1% dextran
Number of subjects: 10
Study 16973668 — intervention group
Group type: COMPARATOR
Intervention: Comparison of sodium hyaluronate vs HPMC/dextran
Number of subjects: 10
Study 15774341 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise programme (12-week intervention)
Number of subjects: 22
Study 15774341 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise programme)
Number of subjects: 22
Study 15774341 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group exercise programme
Number of subjects: 22
Study 12230149 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer games involving MR skills (experimental group)
Number of subjects: 47
Study 12230149 — intervention group
Group type: COMPARATOR
Intervention: Computer games not involving MR skills (control group)
Number of subjects: 47
Study 10212855 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine eye drops
Number of subjects: 20
Study 10212855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8652692 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary HIV counselling and testing (IC group)
Number of subjects: 0
Study 8652692 — intervention group
Group type: COMPARATOR
Intervention: Control group (AC group)
Number of subjects: 0
Study 2363529 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg of dTC
Number of subjects: 60
Study 2363529 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 60
Study 527353 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphinpyrazone
Number of subjects: 7
Study 527353 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7
Study 30888702 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-RPA194 antibodies
Number of subjects: 168
Study 30888702 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-RPC155 with anti-RPA194
Number of subjects: 168
Study 29061612 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anaesthesia (RA)
Number of subjects: 1000
Study 29061612 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 1000
Study 25009199 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait training with auditory feedback for 30 minutes, five times a week for four weeks
Number of subjects: 22
Study 25009199 — intervention group
Group type: COMPARATOR
Intervention: Gait training without auditory feedback for 30 minutes, five times a week for four weeks
Number of subjects: 22
Study 24597923 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual learning environment courseware package
Number of subjects: 35
Study 24597923 — intervention group
Group type: COMPARATOR
Intervention: Traditional learning (lecture-based training)
Number of subjects: 35
Study 21603859 — intervention group
Group type: EXPERIMENTAL
Intervention: HFR dialysis (n=25)
Number of subjects: 40
Study 21603859 — intervention group
Group type: COMPARATOR
Intervention: HD-PS dialysis (n=15)
Number of subjects: 40
Study 20387748 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatrial pacing
Number of subjects: 210
Study 20387748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone
Number of subjects: 210
Study 20387748 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 210
Study 17449511 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-FSH
Number of subjects: 151
Study 17449511 — intervention group
Group type: COMPARATOR
Intervention: rFSH
Number of subjects: 151
Study 16331341 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (transcutaneous electrical nerve stimulation) used postoperatively on 60 patients for 5 days.
Number of subjects: 116
Study 16331341 — intervention group
Group type: COMPARATOR
Intervention: Control group (56 patients without TENS).
Number of subjects: 116
Study 12466925 — intervention group
Group type: EXPERIMENTAL
Intervention: Central Capacity Sharing model
Number of subjects: 0
Study 12466925 — intervention group
Group type: COMPARATOR
Intervention: Central Bottleneck model
Number of subjects: 0
Study 9695722 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin infusion (7.5 to 15 to 30 ng.kg body weight‐1.min‐1)
Number of subjects: 12
Study 9695722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7734467 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist/patient matching by gender and race for the intake interview
Number of subjects: 634
Study 7734467 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuity by having the intake therapist become the treatment therapist
Number of subjects: 634
Study 7734467 — intervention group
Group type: COMPARATOR
Intervention: Eight different therapists conducting intake interviews
Number of subjects: 634
Study 2659955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (50 mg i.m. every 3 weeks for 12 months)
Number of subjects: 20
Study 2659955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29289931 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues (color)
Number of subjects: 300
Study 29289931 — intervention group
Group type: COMPARATOR
Intervention: Informational cues (claim/label)
Number of subjects: 300
Study 26847236 — intervention group
Group type: EXPERIMENTAL
Intervention: ImageJ‐based method
Number of subjects: 765
Study 26847236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulus approach
Number of subjects: 765
Study 26847236 — intervention group
Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 765
Study 26555004 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonweighted decisional balance intervention
Number of subjects: 162
Study 26555004 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted decisional balance intervention
Number of subjects: 162
Study 26555004 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 162
Study 23071237 — intervention group
Group type: EXPERIMENTAL
Intervention: RT/PCV (radiotherapy followed by six cycles of procarbazine, lomustine, and vincristine)
Number of subjects: 368
Study 23071237 — intervention group
Group type: COMPARATOR
Intervention: RT (radiotherapy only)
Number of subjects: 368
Study 20847618 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier retractional wound protection
Number of subjects: 130
Study 20847618 — intervention group
Group type: COMPARATOR
Intervention: Standard wound retraction
Number of subjects: 130
Study 18164988 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory attention experiment
Number of subjects: 66
Study 18164988 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual attention experiment
Number of subjects: 66
Study 18164988 — intervention group
Group type: EXPERIMENTAL
Intervention: Hanoi experiment
Number of subjects: 66
Study 17083882 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical calcineurin inhibitors (pimecrolimus and tacrolimus)
Number of subjects: 0
Study 17083882 — intervention group
Group type: COMPARATOR
Intervention: FDA black box warning on topical calcineurin inhibitors
Number of subjects: 0
Study 14680078 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 320/9 microg
Number of subjects: 1022
Study 14680078 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 400 microg
Number of subjects: 1022
Study 14680078 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 9 microg
Number of subjects: 1022
Study 14680078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1022
Study 11679530 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramural fibroids (n = 106 with fibroids ≤5 cm)
Number of subjects: 434
Study 11679530 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 322 without fibroids)
Number of subjects: 434
Study 11679530 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of intramural fibroids
Number of subjects: 434
Study 9467150 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up by community optometrists
Number of subjects: 403
Study 9467150 — intervention group
Group type: COMPARATOR
Intervention: Follow-up by hospital eye service
Number of subjects: 403
Study 7941942 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 40 mg.kg‐1.d‐1, divided into four equal doses
Number of subjects: 81
Study 7941942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 2453705 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl-starch (200/0.5 10%)
Number of subjects: 60
Study 2453705 — intervention group
Group type: EXPERIMENTAL
Intervention: Laevulose 5%
Number of subjects: 60
Study 2453705 — intervention group
Group type: COMPARATOR
Intervention: Whole blood (no processing)
Number of subjects: 60
Study 29209731 — intervention group
Group type: EXPERIMENTAL
Intervention: KAT plus a conventional rehabilitation programme
Number of subjects: 64
Study 29209731 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation programme
Number of subjects: 64
Study 28398347 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT) from healthy donors or autologous faeces
Number of subjects: 0
Study 28398347 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 0
Study 25992279 — intervention group
Group type: EXPERIMENTAL
Intervention: iloprost 2.5 µg
Number of subjects: 126
Study 25992279 — intervention group
Group type: EXPERIMENTAL
Intervention: iloprost 5.0 µg
Number of subjects: 126
Study 25992279 — intervention group
Group type: EXPERIMENTAL
Intervention: iloprost 2.5 µg or 5.0 µg in iPAH subset
Number of subjects: 126
Study 24617227 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulating spleen-stomach needling
Number of subjects: 144
Study 24617227 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment of diabetes (Control group)
Number of subjects: 144
Study 21909606 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo NiTi rotary system
Number of subjects: 97
Study 21909606 — intervention group
Group type: COMPARATOR
Intervention: K file
Number of subjects: 97
Study 18420953 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic Transluminal Balloon Angioplasty (pTBA)
Number of subjects: 170
Study 16595025 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 11700
Study 16595025 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 11700
Study 12624551 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (20 ml 0.375% bupivacaine through L(3‐4) inter‐space)
Number of subjects: 30
Study 12624551 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (4 mg.kg(‐1) thiopental and 1.5 mg.kg(‐1) succinylcholine)
Number of subjects: 30
Study 11112112 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT)
Number of subjects: 44
Study 11112112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 9509181 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine/Chlorpheniramine combination
Number of subjects: 98
Study 9509181 — intervention group
Group type: COMPARATOR
Intervention: Mefloquine
Number of subjects: 98
Study 30386327 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy protein (UV-C treated)
Number of subjects: 21
Study 30386327 — intervention group
Group type: COMPARATOR
Intervention: Soy isoflavone protein (control)
Number of subjects: 21
Study 27267111 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol succinate
Number of subjects: 1028
Study 27267111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1028
Study 24862763 — intervention group
Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude (HVLA) spinal manipulation (SM) in the treatment group (n=20)
Number of subjects: 40
Study 24862763 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention in the control group (n=20)
Number of subjects: 40
Study 22564228 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Negative Pressure (SNaP) Wound Care System
Number of subjects: 132
Study 22564228 — intervention group
Group type: COMPARATOR
Intervention: Vacuum‐Assisted Closure (VAC) Therapy System
Number of subjects: 132
Study 22564228 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SNaP and VAC systems
Number of subjects: 132
Study 19325998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-water-spray
Number of subjects: 24
Study 19325998 — intervention group
Group type: EXPERIMENTAL
Intervention: CoolPack
Number of subjects: 24
Study 16974175 — intervention group
Group type: EXPERIMENTAL
Intervention: Music listening
Number of subjects: 0
Study 16295047 — intervention group
Group type: EXPERIMENTAL
Intervention: lercanidipine 10-20 mg/day
Number of subjects: 277
Study 16295047 — intervention group
Group type: COMPARATOR
Intervention: ramipril 5-10 mg/day
Number of subjects: 277
Study 11408852 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin, 500 mg, three times daily for 7 days
Number of subjects: 129
Study 11408852 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin, 1 g, single dose
Number of subjects: 129
Study 9457403 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled IL-2 therapy (high-dose inhalation)
Number of subjects: 116
Study 10150180 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.75 U APSAC
Number of subjects: 103
Study 10150180 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 U APSAC
Number of subjects: 103
Study 10150180 — intervention group
Group type: EXPERIMENTAL
Intervention: 15.0 U APSAC
Number of subjects: 103
Study 10150180 — intervention group
Group type: EXPERIMENTAL
Intervention: 30.0 U APSAC
Number of subjects: 103
Study 10150180 — intervention group
Group type: EXPERIMENTAL
Intervention: All APSAC groups
Number of subjects: 103
Study 10150180 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 103
Study 3654947 — intervention group
Group type: EXPERIMENTAL
Intervention: SV vaccine (one dose)
Number of subjects: 104
Study 3654947 — intervention group
Group type: EXPERIMENTAL
Intervention: SV vaccine (two doses)
Number of subjects: 104
Study 3654947 — intervention group
Group type: EXPERIMENTAL
Intervention: WV vaccine (one dose)
Number of subjects: 104
Study 3654947 — intervention group
Group type: EXPERIMENTAL
Intervention: WV vaccine (two doses)
Number of subjects: 104
Study 3654947 — intervention group
Group type: COMPARATOR
Intervention: Both vaccines (one or two doses)
Number of subjects: 104
Study 3654947 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose (one month after first dose)
Number of subjects: 104
Study 29195125 — intervention group
Group type: EXPERIMENTAL
Intervention: STABLE + PHARM (ECT plus medications)
Number of subjects: 120
Study 29195125 — intervention group
Group type: COMPARATOR
Intervention: PHARM (medications alone)
Number of subjects: 120
Study 28134748 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 2600
Study 28134748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2600
Study 25314004 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-collagen chelate (CC) dietary supplement (5g containing 500mg of elemental calcium and 200IU vitamin D)
Number of subjects: 39
Study 25314004 — intervention group
Group type: COMPARATOR
Intervention: Control (500mg of calcium and 200IU vitamin D)
Number of subjects: 39
Study 23114538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose control (target blood glucose 80‐120 mg/dL)
Number of subjects: 67
Study 23114538 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose control (target blood glucose <180 mg/dL)
Number of subjects: 67
Study 23114538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glucose control
Number of subjects: 67
Study 23114538 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose control
Number of subjects: 67
Study 21124762 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 therapy
Number of subjects: 12
Study 21124762 — intervention group
Group type: COMPARATOR
Intervention: cART only (control)
Number of subjects: 12
Study 18474769 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-vision rehabilitation program including low-vision examination, counseling, prescription and provision of low-vision devices, and 6 weekly sessions with a low-vision therapist.
Number of subjects: 126
Study 18474769 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-vision rehabilitation program
Number of subjects: 126
Study 18474769 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 126
Study 16776699 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill stress test in non-hypertensive cephalalgia sufferers (Ce)
Number of subjects: 150
Study 16776699 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill stress test in hypertensive cephalalgia sufferers (HyCe)
Number of subjects: 150
Study 16776699 — intervention group
Group type: COMPARATOR
Intervention: Treadmill stress test in healthy subjects (C)
Number of subjects: 150
Study 14756604 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient activation
Number of subjects: 159
Study 14756604 — intervention group
Group type: COMPARATOR
Intervention: Passive education
Number of subjects: 159
Study 10668769 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 900 mg orally three times a day
Number of subjects: 0
Study 10668769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10668769 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 9493483 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 671
Study 9493483 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671
Study 8095894 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg
Number of subjects: 8
Study 8095894 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertatolol 5 mg + Prazosin 1 mg
Number of subjects: 8
Study 8095894 — intervention group
Group type: COMPARATOR
Intervention: Prazosin 1 mg
Number of subjects: 8
Study 8095894 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8095894 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of drugs
Number of subjects: 8
Study 3090959 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (1,500,000 U in 30 mn)
Number of subjects: 101
Study 3090959 — intervention group
Group type: COMPARATOR
Intervention: Conventional heparin therapy
Number of subjects: 101
Study 3090959 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase
Number of subjects: 101
Study 30996007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks for up to 24 months
Number of subjects: 371
Study 28460534 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR[BC]) program
Number of subjects: 322
Study 28460534 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 322
Study 25569529 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote control injection system (Group B)
Number of subjects: 44
Study 23031804 — intervention group
Group type: EXPERIMENTAL
Intervention: TEASAP (Treatment-Emergent Activation and Suicidality Assessment Profile)
Number of subjects: 56
Study 23031804 — intervention group
Group type: EXPERIMENTAL
Intervention: TEASAP Disinhibition subscale
Number of subjects: 56
Study 23031804 — intervention group
Group type: EXPERIMENTAL
Intervention: TEASAP scores
Number of subjects: 56
Study 21437615 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgimesh WN (non‐woven polypropylene microfibre sheet)
Number of subjects: 202
Study 21437615 — intervention group
Group type: COMPARATOR
Intervention: Heavy weight polypropylene mesh
Number of subjects: 202
Study 18070613 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed summaries
Number of subjects: 87
Study 18070613 — intervention group
Group type: COMPARATOR
Intervention: Immediate summaries
Number of subjects: 87
Study 16515651 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen application (Dermatophagoides farinae and Ctenocephalides felis)
Number of subjects: 7
Study 16515651 — intervention group
Group type: COMPARATOR
Intervention: Saline application (control)
Number of subjects: 7
Study 16515651 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological evaluation after allergen application
Number of subjects: 7
Study 16515651 — intervention group
Group type: EXPERIMENTAL
Intervention: Macroscopic and microscopic evaluations
Number of subjects: 7
Study 15474758 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg buccal estradiol
Number of subjects: 99
Study 15474758 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05, 0.1, 0.2 mg buccal estradiol
Number of subjects: 99
Study 15474758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99